BioSpace News Archive

Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:45 AM ET on Thursday

VerdePharmHealth today announced the signing of an exclusive national agreement with HAI Health for the HealthyDose product line formulated by a highly respected oncologist, Dr. Alberto Bessudo.

Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it has been granted Fast Track designation by the FDA for RBT-9 treatment in COVID-19.

Abbott will announce its second-quarter 2020 financial results on Thursday, July 16, 2020, before the market opens.

Oculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments to improve the sight and lives of patients, today announced that Riad Sherif M.D., CEO, plans to present an overview of the company at the upcoming Virtual European Biotech Investor Day 2020

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its continued commitment to people who suffer from migraines during National Migraine & Headache Awareness Month (MHAM). The COVID-19 pandemic has made it

Fresenius Kabi Expands MicroVault ® Packaging to include Simplist ® Morphine Sulfate Injection, USP Ready-to-Administer Prefilled Syringes

ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and POINT Biopharma Inc., a clinical oncology company, announced today that they have signed two supply agreements for the medical radioisotope no-carrier-added Lutetium-177 (n.c.a. 177Lu) / EndolucinBeta® to support clinical and commercial supply of PNT2002, a 177Lu-PSMA radiopharmaceutical for prostate cancer treatment.

AgBiome®, a leader in developing innovative products from the Earth’s microbial communities, has announced the submission of Theia™ fungicide, its next product, to the EPA for review.

In a new survey conducted by the Lupus Foundation of America, 55% of respondents taking antimalarials to manage their lupus reported having difficulty accessing their prescription for hydroxychloroquine or chloroquine, during March – May 2020 of the coronavirus pandemic.